Trial Profile
A Retrospective study of Sustained-Release Intravitreal Dexamethasone implant (Ozurdex) in patients with TB-associated multifocal serpiginoid choroiditis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2018
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Choroiditis
- Focus Adverse reactions; Therapeutic Use
- 27 Sep 2018 New trial record